TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
23J Stock 12 Month Forecast
Average Price Target
€29.95
▲(353.77% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for ProMIS Neurosciences in the last 3 months. The average price target is €29.95 with a high forecast of €29.95 and a low forecast of €29.95. The average price target represents a 353.77% change from the last price of €6.60.
Still undervalued? ProMIS Neurosciences keeps $9.50 target price at LeedeLoe said that while Fast Track status doesnt guarantee PMN310 will succeed in future Phase II or III Alzheimers trials, it should help speed up the review process if positive results are submitted.
Still undervalued? ProMIS Neurosciences keeps $9.50 target price at LeedeLoe said that while Fast Track status doesnt guarantee PMN310 will succeed in future Phase II or III Alzheimers trials, it should help speed up the review process if positive results are submitted.
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +27.24% per trade.
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +64.24% per trade.
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +64.24% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
23J Analyst Recommendation Trends
Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
6
6
4
2
2
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
6
4
2
2
In the current month, 23J has received 2Buy Ratings, 0Hold Ratings, and 0Sell Ratings. 23J average Analyst price target in the past 3 months is 29.95.
Each month's total comprises the sum of three months' worth of ratings.
23J Financial Forecast
23J Earnings Forecast
Next quarter’s earnings estimate for 23J is -€0.92 with a range of -€0.92 to -€0.92. The previous quarter’s EPS was -€3.55. 23J beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 23J has Performed in-line its overall industry.
Next quarter’s earnings estimate for 23J is -€0.92 with a range of -€0.92 to -€0.92. The previous quarter’s EPS was -€3.55. 23J beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 23J has Performed in-line its overall industry.
23J Sales Forecast
The previous quarter’s earnings for 23J were €0.00.
The previous quarter’s earnings for 23J were €0.00.
23J Stock Forecast FAQ
What is DE:23J’s average 12-month price target, according to analysts?
Based on analyst ratings, ProMIS Neurosciences’s 12-month average price target is 29.95.
What is DE:23J’s upside potential, based on the analysts’ average price target?
ProMIS Neurosciences has 353.77% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ProMIS Neurosciences a Buy, Sell or Hold?
ProMIS Neurosciences has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is ProMIS Neurosciences’s share price target?
The average share price target for ProMIS Neurosciences is 29.95. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst share price target is €29.95 ,and the lowest forecast is €29.95. The average share price target represents 353.77% Increase from the current price of €6.6.
What do analysts say about ProMIS Neurosciences?
ProMIS Neurosciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of ProMIS Neurosciences?
To buy shares of DE:23J, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.